Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.07 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.076 | 0.7 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |